Home › Companies › KRYSTAL BIOTECH INC. › 2023-2024

KRYSTAL BIOTECH INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and KRYSTAL BIOTECH INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

5Ballot items
254Asset managers
1,747Fund votes
May 17, 2024Meeting date

Results at a glance

Meeting of May 17, 2024: 5 items on KRYSTAL BIOTECH INC.’s Form 8-K, filed May 21, 2024: 2 approved · 3 without a stated outcome.

Material dissent

Elect Director: Julian S. Gangolli 76% of votes cast Outcome not stated Director under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore KRYSTAL BIOTECH INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by KRYSTAL BIOTECH INC.

These tallies are KRYSTAL BIOTECH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KRYSTAL BIOTECH INC. — official shareholder meeting results, meeting held May 17, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Suma M. Krishnan	21,058,004	--	--	1,498,017	2,244,047	93%	Not verified	—
Elect Director: Julian S. Gangolli	17,226,067	--	--	5,329,954	2,244,047	76%	Not verified	—
Elect Director: Catherine Mazzacco	20,382,924	--	--	2,173,097	2,244,047	90%	Not verified	—
2. Ratification of Appointment of Independent Registered Public Accounting Firm	24,769,838	7,438	22,792	--	--	99.9%	Approved	—
3. Non-Binding, Advisory Vote on Named Executive Officer Compensation	21,697,311	851,690	7,020	--	2,244,047	96%	Approved	—

This meeting is also recorded here as May 21, 2024; both records come from the same filing, so the date should be checked against it.

Source: KRYSTAL BIOTECH INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.

How asset managers voted at the KRYSTAL BIOTECH INC. 2023-2024 meeting

Each item below shows how the 254 asset managers that disclosed a KRYSTAL BIOTECH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Catherine Mazzacco

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 20,382,924WITHHELD: 2,173,097

Details: description as filed, official tally, votes by 83 asset managers

Description as filed by funds: Election of Class I Directors: Catherine Mazzacco

KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Catherine Mazzacco”): 20,382,924 for, 2,173,097 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 83 asset managers below reported 9,625,171 for, 14 against, 940,694 withheld, 95,219 abstained.

FOR

FOR: 9,625,171AGAINST: 14ABSTAIN: 95,219WITHHOLD: 940,694

Largest asset managers voting on “Election of Class I Directors: Catherine Mazzacco” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Fidelity	3,613,988	0	0	For
Vanguard	2,370,200	0	0	For
T. Rowe Price	531,854	0	0	For
BlackRock	496,028	0	0	For
Dimensional	0	0	468,691	Withhold
State Street	462,085	0	626	For
Lord Abbett	347,342	0	0	For
Prudential/PGIM	342,273	0	2,414	For
Manager Directed Portfolios	246,194	0	0	For
TIAA	242,516	0	0	For
Charles Schwab	188,778	0	0	For
MUTUAL FUND SERIES TRUST	136,485	0	0	For
Victory Capital	0	0	88,375	Withhold
TimesSquare Capital Management, LLC	84,841	0	0	For
Equitable	47,770	0	23,260	Mixed
Goldman Sachs	0	0	67,089	Withhold
Franklin Custodian Funds	60,000	0	0	For
Nuveen	56,523	0	0	For
Putnam	51,045	0	0	For
John Hancock	36,281	8,033	0	Mixed
Columbia Threadneedle	43,692	0	0	For
Bridge Builder Trust	3,934	39,120	0	Mixed
Jackson National	0	40,316	0	Abstain
Allspring	0	0	39,102	Withhold
Aberdeen	0	0	39,024	Withhold

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

2. Elect Director: Julian S. Gangolli

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD

FOR: 17,226,067WITHHELD: 5,329,954

Details: description as filed, official tally, votes by 83 asset managers

Description as filed by funds: Election of Class I Directors: Julian S. Gangolli

KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Julian S. Gangolli”): 17,226,067 for, 5,329,954 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 83 asset managers below reported 8,907,811 for, 14 against, 1,633,457 withheld, 119,816 abstained.

FORWITHHOLD

FOR: 8,907,811AGAINST: 14ABSTAIN: 119,816WITHHOLD: 1,633,457

Largest asset managers voting on “Election of Class I Directors: Julian S. Gangolli” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Fidelity	3,613,988	0	0	For
Vanguard	2,370,200	0	0	For
T. Rowe Price	531,854	0	0	For
BlackRock	496,028	0	0	For
Dimensional	0	0	468,691	Withhold
State Street	460	0	462,251	Withhold
Lord Abbett	347,342	0	0	For
Prudential/PGIM	342,273	0	2,414	For
Manager Directed Portfolios	246,194	0	0	For
TIAA	242,516	0	0	For
Charles Schwab	188,778	0	0	For
MUTUAL FUND SERIES TRUST	136,485	0	0	For
Victory Capital	0	0	88,375	Withhold
TimesSquare Capital Management, LLC	84,841	0	0	For
Equitable	47,770	0	23,260	Mixed
Goldman Sachs	0	0	67,089	Withhold
Franklin Custodian Funds	0	0	60,000	Withhold
Nuveen	56,523	0	0	For
Putnam	51,045	0	0	For
John Hancock	36,281	8,033	0	Mixed
Columbia Threadneedle	0	0	43,692	Withhold
Bridge Builder Trust	3,934	39,120	0	Mixed
Jackson National	0	40,316	0	Abstain
Allspring	0	0	39,102	Withhold
Aberdeen	0	0	39,024	Withhold

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

3. Elect Director: Suma M. Krishnan

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%

FOR: 21,058,004WITHHELD: 1,498,017

Details: description as filed, official tally, votes by 83 asset managers

Description as filed by funds: Election of Class I Directors: Suma M. Krishnan

KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Suma M. Krishnan”): 21,058,004 for, 1,498,017 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 83 asset managers below reported 9,672,304 for, 980,014 withheld, 8,780 abstained.

FOR

FOR: 9,672,304ABSTAIN: 8,780WITHHOLD: 980,014

Largest asset managers voting on “Election of Class I Directors: Suma M. Krishnan” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Fidelity	3,613,988	0	0	For
Vanguard	2,370,200	0	0	For
T. Rowe Price	531,854	0	0	For
BlackRock	496,028	0	0	For
Dimensional	0	0	468,691	Withhold
State Street	1,033	0	461,678	Withhold
Lord Abbett	347,342	0	0	For
Prudential/PGIM	344,687	0	0	For
Manager Directed Portfolios	246,194	0	0	For
TIAA	242,516	0	0	For
Charles Schwab	188,778	0	0	For
MUTUAL FUND SERIES TRUST	136,485	0	0	For
Victory Capital	88,375	0	0	For
TimesSquare Capital Management, LLC	84,841	0	0	For
Equitable	47,770	0	23,260	Mixed
Goldman Sachs	67,089	0	0	For
Franklin Custodian Funds	60,000	0	0	For
Nuveen	56,523	0	0	For
Putnam	51,045	0	0	For
John Hancock	44,314	0	0	For
Columbia Threadneedle	43,692	0	0	For
Bridge Builder Trust	43,054	0	0	For
Jackson National	34,141	6,175	0	Mixed
Allspring	39,102	0	0	For
Aberdeen	39,024	0	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

4. 3. Non-Binding, Advisory Vote on Named Executive Officer Compensation

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 17 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%

FOR: 21,697,311AGAINST: 851,690

Details: description as filed, official tally, votes by 254 asset managers

Description as filed by funds: APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.

KRYSTAL BIOTECH INC.’s own tally for this item (“3. Non-Binding, Advisory Vote on Named Executive Officer Compensation”): 21,697,311 for, 851,690 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three: Non-Binding, Advisory Vote on Named Executive Officer Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2023, as disclosed in the Company's proxy sta…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 83 asset managers voting on “APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Against	Vote
Fidelity	3,613,988	0	For
Vanguard	2,370,200	0	For
T. Rowe Price	531,854	0	For
BlackRock	496,028	0	For
Dimensional	468,691	0	For
State Street	462,711	0	For
Lord Abbett	347,342	0	For
Prudential/PGIM	344,687	0	For
Manager Directed Portfolios	246,194	0	For
TIAA	242,516	0	For
Charles Schwab	188,778	0	For
MUTUAL FUND SERIES TRUST	136,485	0	For
Victory Capital	88,375	0	For
Equitable	71,030	0	For
Goldman Sachs	67,089	0	For
Franklin Custodian Funds	60,000	0	For
Nuveen	56,523	0	For
Putnam	51,045	0	For
John Hancock	44,314	0	For
Columbia Threadneedle	43,692	0	For
Bridge Builder Trust	43,054	0	For
Jackson National	40,316	0	For
Allspring	39,102	0	For
Aberdeen	0	39,024	Against
QUANTITATIVE MASTER SERIES LLC	38,159	0	For

Fund voting reports, all 83 managers: 10,537,576 for, 39,634 against, 2,820 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 193 asset managers voting on “APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Against	Vote
Fidelity	4,243,326	0	For
Redmile Group, LLC	1,508,250	0	For
State Street	886,159	0	For
T. Rowe Price	655,737	0	For
JENNISON ASSOCIATES LLC	587,696	1,364	For
BlackRock	539,055	0	For
GEODE CAPITAL MANAGEMENT, LLC	497,283	0	For
Hood River Capital Management LLC	463,142	0	For
LORD, ABBETT & CO. LLC	425,363	0	For
Nuveen	324,578	0	For
UBS	0	265,652	Against
Woodline Partners LP	252,526	0	For
SEB Investment Management AB	0	244,061	Against
Charles Schwab	188,800	0	For
Northern Trust	180,912	15	For
JPMorgan	168,698	0	For
Victory Capital	158,022	0	For
Man Group plc	0	157,550	Against
C WorldWide Asset Management Fondsmaeglerselskab A/S	0	135,809	Against
PICTET ASSET MANAGEMENT SA	111,098	0	For
Rock Springs Capital Management LP	100,773	0	For
MELLON INVESTMENTS Corp	90,400	0	For
S Squared Technology, LLC	90,215	0	For
Vestal Point Capital, LP	85,979	0	For
TimesSquare Capital Management, LLC	84,841	0	For

Institutional-manager reports, all 193 managers: 13,117,519 for, 960,407 against, 326 abstained. Showing the 25 largest; see all in the interactive database.

5. 2. Ratification of Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%

FOR: 24,769,838AGAINST: 7,438

Details: description as filed, official tally, votes by 87 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2024.

KRYSTAL BIOTECH INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 24,769,838 for, 7,438 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 87 asset managers below reported 10,662,371 for, 81 against, 2,820 abstained.

FOR

FOR: 10,662,371AGAINST: 81ABSTAIN: 2,820

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR” at KRYSTAL BIOTECH INC., 2023-2024
Asset manager	For	Vote
Fidelity	3,613,988	For
Vanguard	2,370,200	For
T. Rowe Price	531,854	For
BlackRock	496,028	For
Dimensional	468,691	For
State Street	462,711	For
Lord Abbett	347,342	For
Prudential/PGIM	344,687	For
Manager Directed Portfolios	246,194	For
TIAA	242,516	For
Charles Schwab	188,778	For
MUTUAL FUND SERIES TRUST	136,485	For
Victory Capital	88,375	For
TimesSquare Capital Management, LLC	84,841	For
Equitable	71,030	For
Goldman Sachs	67,089	For
Franklin Custodian Funds	60,000	For
Nuveen	56,523	For
Putnam	51,045	For
John Hancock	44,314	For
Columbia Threadneedle	43,692	For
Bridge Builder Trust	43,054	For
Jackson National	40,316	For
Allspring	39,102	For
Aberdeen	39,024	For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

Largest KRYSTAL BIOTECH INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,528,000 shares outstanding at the time of that meeting.

Fund voting reports: top KRYSTAL BIOTECH INC. shareholders by shares voted on “APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Fidelity	12.67%
2	Vanguard	8.31%
3	T. Rowe Price	1.86%
4	BlackRock	1.74%
5	Dimensional	1.64%
6	State Street	1.62%
7	Lord Abbett	1.22%
8	Prudential/PGIM	1.21%
9	Manager Directed Portfolios	0.86%
10	TIAA	0.85%

Institutional-manager reports: top KRYSTAL BIOTECH INC. shareholders by shares voted on “APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Fidelity	14.87%
2	Redmile Group, LLC	5.29%
3	State Street	3.11%
4	T. Rowe Price	2.30%
5	JENNISON ASSOCIATES LLC	2.06%
6	BlackRock	1.89%
7	GEODE CAPITAL MANAGEMENT, LLC	1.74%
8	Hood River Capital Management LLC	1.62%
9	LORD, ABBETT & CO. LLC	1.49%
10	Nuveen	1.14%

Reported KRYSTAL BIOTECH INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

KRYSTAL BIOTECH INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
FMR (Fidelity)	15.22%	13F
BlackRock	13.44%	13F
FMR LLC	11.74%	DEF14A
Vanguard Group	9.79%	13F
Avoro Capital Advisors LLC	8.99%	DEF14A
Krish S. Krishnan	6.43%	DEF14A
Suma M. Krishnan	6.15%	DEF14A
Redmile Group, LLC	6.08%	DEF14A
State Street	3.31%	13F
T. Rowe Price	2.31%	13F

Percentages above are of 28,528,000 shares outstanding, as reported by KRYSTAL BIOTECH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KRYSTAL BIOTECH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At KRYSTAL BIOTECH INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 254 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,747 separate fund positions. On the most widely held item on that ballot — APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING… — KRYSTAL BIOTECH INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KRYSTAL BIOTECH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.

KRYSTAL BIOTECH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.